FDA OKs first fully interoperable glucose monitoring system: 4 things to know

The FDA on March 27 permitted the marketing of the Dexcom G6 integrated continuous glucose monitoring system for diabetes patients age 2 and older.

Here are four things to know about the device.

1. The Dexcom G6 is a quarter-sized patch device worn on a patient's abdomen and changed every 10 days.

2. The patch contains a small sensor that monitors the amount of glucose in body fluid and transmits real-time glucose readings every five minutes to a compatible display device.

3. The Dexcom G6 is the first continuous glucose monitoring system to work with other compatible medical devices, including automated insulin dosing systems, insulin pumps and blood glucose meters.

4. Dexcom plans to launch the device later this year.

More articles on supply chain:

Study: 40% of providers have canceled surgeries over supply shortages
10 immensely overinflated hospital costs
California leads way on drug pricing transparency with other states poised to follow: 6 things to know

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.